|
|
Article: Three Studies Support Long-term Use of Trileptal-R- in Patients with Partial Seizures.
- Article from:
- Business Wire
- Article date:
- December 10, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
EAST HANOVER, N.J.--(BUSINESS WIRE)--Dec. 10, 2002
The antiepileptic drug (AED) Trileptal (R) (oxcarbazepine, Novartis Pharmaceuticals Corporation) maintains efficacy during long-term treatment in patients with partial seizures, according to data from the two-year open-label extension phases of three studies. The results were presented at the 56th annual meeting of the American Epilepsy Society.
"The ability of an anti-epilepsy medication to gain and maintain control of seizures over an extended period of time is an important characteristic," said Tracy Glauser, M.D., director of the Comprehensive Epilepsy ...